Product Information

DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1428 per EA under NDC 76385010710. Its NADAC has been published 362 times since Dec 11, 2019.

FDA first approved this application on Nov 13, 2018. Its Orange Book therapeutic-equivalence code is AA.

DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET

Diphenoxylate Hydrochloride and Atropine Sulfate
$0.1428per EA
DEA Schedule CV

Strength

.025; 2.5 mg/1; mg/1

NDC

76385010710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210819

FDA Approved

11/13/2018

TE Code

AA

On Market Since

5/15/2019

Pharmacological Classes

Anticholinergic
Antidiarrheal
Cholinergic Antagonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 362 times since Dec 11, 2019, and over the history we have for it it has declined 51.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1428 per EA
All-time high$0.2930 (Dec 11, 2019)
All-time low$0.1298 (Nov 20, 2024)
52-week high$0.1660
52-week low$0.1371
Median price$0.1961
Average price$0.1974
Largest weekly change+55.5% (Aug 21, 2024)
Weeks tracked362
Tracking sinceDec 11, 2019

Price History

1W

0.0%

1M

+2.9%

3M

+4.2%

6M

+0.5%

1Y

-14.8%

3Y

-11.4%

5Y

-29.0%

All

-51.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1428 per EA (NDC 76385010710), effective Nov 11, 2026.

How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?

Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has declined 51.3%. It has been tracked across 362 weekly CMS publications since Dec 11, 2019.

What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?

Since Dec 11, 2019, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1298 (Nov 20, 2024) to a high of $0.2930 (Dec 11, 2019), with a median of $0.1961 per EA.

Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?

DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 76385010710) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.